BioSpace News Archive

Biotech Bay

Eiger BioPharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference

Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a corporate update at the 2018 Wedbush PacGrow Healthcare Conference on August 15 at 2:30 PM ET.

August 7, 2018
·
1 min read
Biotech Bay

Credence MedSystems Closes $12.8 Million Series B Financing

Funding will support ongoing development and scaling of Credence’s family of innovative drug delivery products

August 7, 2018
·
2 min read
NTT Takes New Steps to Grow Its Global Business, Drive Innovation Going Forward

Nippon Telegraph and Telephone Corporation (NTT Corporation) (TOKYO: 9432) is pleased to announce several initiatives to be implemented soon.

August 7, 2018
·
4 min read
Business

TSO3 Reports Second Quarter 2018 Results

TSO3 Inc. reported financial results for the second fiscal quarter ended June 30, 2018.

August 7, 2018
·
17 min read
Business

Medpace Holdings, Inc. Announces Pricing of Secondary Offering of 675,000 shares of Common Stock by Selling Shareholder

Medpace Holdings, Inc. announced the pricing of the previously announced secondary offering of 4,500,000 shares of its common stock by investment funds affiliated with Cinven Capital Management (V) General Partner Limited (the “Selling Shareholder”) at a public offering price of $55.00 per share.

August 7, 2018
·
4 min read
Biotech Bay

Natera Clinical Study Validates New Biomarker for Aneuploidy and Adverse Pregnancy Outcomes

Study Highlights Proprietary Technology for Fetal Fraction Measurement in Non-Invasive Prenatal Testing

August 7, 2018
·
5 min read
Business

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2019 Financial Results on August 10, 2018

Elite Pharmaceuticals, Inc. announced that the first quarter financial results of the 2019 fiscal year will be released on Thursday, August 9, 2018.

August 7, 2018
·
3 min read
FDA

FDA Approves ORKAMBI® (lumacaftor/ivacaftor) as First Medicine to Treat the Underlying Cause of Cystic Fibrosis for Children Ages 2-5 Years with Most Common Form of the Disease

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI®.

August 7, 2018
·
9 min read
Drug Development

Lafayette General Medical Center Unveils Xenex LightStrike Germ-Zapping Robots

New technology destroys deadly pathogens and bacteria lurking on hospital surfaces

August 7, 2018
·
4 min read
BioCapital

United Therapeutics Corporation To Present At 2018 Wedbush PacGrow Healthcare Conference

United Therapeutics Corporation announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company’s business at the 2018 Wedbush PacGrow Healthcare Conference in New York City.

August 7, 2018
·
1 min read